These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 15017381)
21. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Kushibiki T; Matsumoto K; Nakamura T; Tabata Y Gene Ther; 2004 Aug; 11(15):1205-14. PubMed ID: 15103321 [TBL] [Abstract][Full Text] [Related]
22. NK3 and NK4 of HGF enhance filamin production via STAT pathway, but not NK1 and NK2 in human breast cancer cells. Yin YL; Chen HL; Kuo HM; He SP Acta Pharmacol Sin; 2008 Jun; 29(6):728-35. PubMed ID: 18501120 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597 [TBL] [Abstract][Full Text] [Related]
24. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma. Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519 [TBL] [Abstract][Full Text] [Related]
26. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Parr C; Davies G; Nakamura T; Matsumoto K; Mason MD; Jiang WG Biochem Biophys Res Commun; 2001 Aug; 285(5):1330-7. PubMed ID: 11478803 [TBL] [Abstract][Full Text] [Related]
27. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544 [TBL] [Abstract][Full Text] [Related]
28. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. Yu HK; Ahn JH; Lee HJ; Lee SK; Hong SW; Yoon Y; Kim JS J Gene Med; 2005 Jan; 7(1):39-49. PubMed ID: 15517541 [TBL] [Abstract][Full Text] [Related]
29. [Growth suppression of subcutaneous tumor by CT26 expressing NK4 in syngeneic mice]. Kubota T; Fujiwara H; Amaike H; Takashima K; Inada S; Atsuji K; Yoshimura M; Matsumoto K; Nakamura T; Yamagishi H Gan To Kagaku Ryoho; 2002 Nov; 29(12):2258-60. PubMed ID: 12484049 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973 [TBL] [Abstract][Full Text] [Related]
31. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931 [TBL] [Abstract][Full Text] [Related]
32. Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival. Saga Y; Mizukami H; Suzuki M; Urabe M; Kume A; Nakamura T; Sato I; Ozawa K Gene Ther; 2001 Oct; 8(19):1450-5. PubMed ID: 11593357 [TBL] [Abstract][Full Text] [Related]
33. NK4 gene therapy targeting HGF-Met and angiogenesis. Matsumoto K; Nakamura T Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681 [TBL] [Abstract][Full Text] [Related]
34. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789 [TBL] [Abstract][Full Text] [Related]
35. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672 [TBL] [Abstract][Full Text] [Related]
36. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351 [TBL] [Abstract][Full Text] [Related]
37. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621 [TBL] [Abstract][Full Text] [Related]
38. [Suppression of peritoneal implantation by NK4 and its mechanisms]. Atsuji K; Fujiwara H; Kubota T; Inada S; Takashima K; Yoshimura M; Ueda Y; Yamagishi H Gan To Kagaku Ryoho; 2004 Oct; 31(11):1777-9. PubMed ID: 15553712 [TBL] [Abstract][Full Text] [Related]